Mitochondrial Abundant Heat Soluble (MAHS) Protein Expression Modulates Metabolic Dynamics in Human Adipose-Derived Stem Cells
International Journal of Molecular Sciences · 15.07.2026 · 27 (14) · 6289
DOI: 10.3390/ijms27146289 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 15.07.2026. Verfasst von Jordan L Rolsma und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, University of California, Riverside, CA 92521, USA. Hauptthemen laut MEDLINE: Stem Cells, Mitochondria, Mitochondrial Proteins, Adipose Tissue. Die Arbeit nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: American Heart Association, NIDCR NIH HHS, U.S. National Science Foundation.
Abstract (Originalsprache)
Adipose-derived stem cells (ASCs) possess substantial regenerative potential, with lineage fate tightly coupled to metabolic dynamics. In prior work, we found that expression of the tardigrade-derived protein Mitochondrial Abundant Heat Soluble (MAHS) increased stress tolerance and promoted ASC osteogenic differentiation over adipogenic differentiation, although the mechanism remained unclear. Here, we leverage transcriptomic and functional assays to investigate how MAHS expression influences ASC metabolism. Transcriptomic profiling revealed incomplete adipogenic activation alongside upregulation of ossification-associated genes (e.g., SERPINF1), as well as broader changes in metabolic, Wnt, and YAP signaling pathways consistent with a shift toward osteogenic programming. Functionally, MAHS-expressing ASCs exhibited increased matrix calcium deposition in osteogenic culture, as well as decreased ATP and cAMP levels during basal culture. Further, treatment with forskolin increased cAMP levels, while forskolin or Compound C increased lipid accumulation in MAHS-expressing ASCs. Together, these findings suggest that MAHS expression perturbs metabolic dynamics and signaling networks in ASCs and may contribute to impaired adipogenesis and reinforcement of osteogenic bias. More broadly, this work highlights potential regulatory points that could be targeted to restore lineage balance in metabolically disrupted ASCs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bioengineering, University of California, Riverside, CA 92521, USA.
- Department of Molecular, Cell & Systems Biology, University of California, Riverside, CA 92521, USA.
- Stem Cell Center, College of Natural and Agricultural Sciences, University of California, Riverside, CA 92521, USA.
ORCID-Profile: Ruthia Soh, Nicole Zur Nieden, Joshua T Morgan
Förderung
- American Heart Association
- NIDCR NIH HHS
- U.S. National Science Foundation
- California Space Grant Consortium
- California Institute for Regenerative Medicine
- US National Science Foundation
- California Institute of Regenerative Medicine
- National Science Foundation Graduate Research Fellowship Program
Zitieren
APA
Rolsma, J. L., Li, J., Soh, R., Nieh, C., Yeh, B., Darch, W., Nieden, N. Z., & Morgan, J. T. (2026). Mitochondrial Abundant Heat Soluble (MAHS) Protein Expression Modulates Metabolic Dynamics in Human Adipose-Derived Stem Cells. International Journal of Molecular Sciences, 27(14), 6289. https://doi.org/10.3390/ijms27146289
Vancouver
Rolsma JL, Li J, Soh R, Nieh C, Yeh B, Darch W, et al. Mitochondrial Abundant Heat Soluble (MAHS) Protein Expression Modulates Metabolic Dynamics in Human Adipose-Derived Stem Cells. International Journal of Molecular Sciences. 2026;27(14):6289. doi:10.3390/ijms27146289
BibTeX
@article{Rolsma2026,
author = {Rolsma, Jordan L and Li, Julieanna and Soh, Ruthia and Nieh, Connor and Yeh, Bryce and Darch, William and Nieden, Nicole Zur and Morgan, Joshua T},
title = {Mitochondrial Abundant Heat Soluble (MAHS) Protein Expression Modulates Metabolic Dynamics in Human Adipose-Derived Stem Cells},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {14},
pages = {6289},
doi = {10.3390/ijms27146289}
}
EUVIMED